Data Usage Among other things, our MeDIC provides data according to the specifications and regulations of the MII . All university hospitals connected to the MII infrastructure have agreed on a common

The Use Case ACRIBiS Cardiology Personalised risk assessment of cardiovascular diseases is intended to be part of the dynamically learning healthcare system of the future. This is the focus of the use

The Use Case PM4Onco Oncology The use case PM4Onco ( P ersonalised M edicine for ( 4 ) Onco logy) aims to advance personalised medicine in cancer treatment. For this purpose, a permanent infrastructur

The Use Case CALM-QE Pediatric Pulmology Chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA) are the most common non-communicable lung diseases with significant socioeconomic impact

The Use Case RISK PRINCIPE Infectiology Nosocomial infections - i.e. infections acquired in a hospital or a care facility - represent a great burden for the patients affected, the health care staff an

Open positions Master, PhD, PostDoc We are always looking for qualified people who are interested in working at the Institute of Immunology. Our institute offers the possibility to work in an internat

2. Funding period (NUM 2.0): 2022–2025 NUM-Projects of the 2. funding period at the MHH AKTIN 2.0 / AKTIN - Notaufnahmeregister Project leader: Dr. Torben Brod, MD Department / Institute: Emergency De

1. Funding period (NUM 1.0): 2020–2021 NUM-Projects of 1. funding period at the MHH B-FAST / National Research Network "Applied Surveillance and Testing" Project leader: Prof. Dr. Reinhold Förster Dep

FOR 2799 Receiving and Translating Signals via the γδ T Cell Receptor Speaker: Professor Dr. Immo Prinz Hannover Medical School Institute of Immunology Carl-Neuberg-Straße 1 30625 Hannover Phone: +49